Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             255 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Achalasia Boeckxstaens, G.E.E.
2007
50-51 4 p. 595-608
14 p.
artikel
2 Acute colonic pseudo-obstruction Saunders, Michael D.
2007
50-51 4 p. 671-687
17 p.
artikel
3 Adenoma detection rate and risk of colorectal cancer Wieszczy, P.
2017
50-51 4 p. 441-446
6 p.
artikel
4 Adipose tissues as endocrine target organs Lanthier, Nicolas
2014
50-51 4 p. 545-558
14 p.
artikel
5 Advanced endoscopic imaging for early gastric cancer Kaise, Mitsuru
2015
50-51 4 p. 575-587
13 p.
artikel
6 Advances in alcoholic liver disease Arteel, Gavin
2003
50-51 4 p. 625-647
23 p.
artikel
7 Aetiology, molecular pathogenesis and genetics Rindi, Guido
2005
50-51 4 p. 519-534
16 p.
artikel
8 Aetiopathogenesis of primary sclerosing cholangitis Cullen, Sue
2001
50-51 4 p. 577-589
13 p.
artikel
9 Aflatoxin and liver cancer Jackson, Peta E.
1999
50-51 4 p. 545-555
11 p.
artikel
10 Aims & Scope/ Editorial Board 2009
50-51 4 p. iii-
1 p.
artikel
11 Aims & Scope/ Editorial Board 2015
50-51 4 p. iii-
1 p.
artikel
12 Aims & Scope/ Editorial Board 2016
50-51 4 p. iii-
1 p.
artikel
13 Aims & Scope/ Editorial Board 2013
50-51 4 p. iii-
1 p.
artikel
14 Aims & Scope/ Editorial Board 2012
50-51 4 p. iii-
1 p.
artikel
15 Aims & scope/editorial board 2006
50-51 4 p. iii-
1 p.
artikel
16 Aims ; scope/editorial board 2004
50-51 4 p. iii-
1 p.
artikel
17 Aims & scope/editorial board 2007
50-51 4 p. iii-
1 p.
artikel
18 Aims & Scope/ Editorial Board 2010
50-51 4 p. iii-
1 p.
artikel
19 Aims & scope/editorial board 2005
50-51 4 p. iii-
1 p.
artikel
20 Aims & Scope/ Editorial Board 2014
50-51 4 p. iii-
1 p.
artikel
21 Aims & scope/editorial board 2008
50-51 4 p. iii-
1 p.
artikel
22 Aims & Scope/ Editorial Board 2017
50-51 4 p. iii-
1 p.
artikel
23 Alcohol addiction research: from animal models to clinics Spanagel, Rainer
2003
50-51 4 p. 507-518
12 p.
artikel
24 Alcohol consumption and cancer of the gastrointestinal tract Salaspuro, Mikko P.
2003
50-51 4 p. 679-694
16 p.
artikel
25 Alcohol consumption and total mortality/morbidity—definitions and methodological implications Rehm, Jürgen
2003
50-51 4 p. 497-505
9 p.
artikel
26 Alcohol-induced pancreatic injury Apte, M.V
2003
50-51 4 p. 593-612
20 p.
artikel
27 Alcohol-related diseases of the mouth and throat Riedel, Frank
2003
50-51 4 p. 543-555
13 p.
artikel
28 Alcohol-related diseases of the oesophagus and stomach Teyssen, Stephan
2003
50-51 4 p. 557-573
17 p.
artikel
29 Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome Delvaux, Michel
2004
50-51 4 p. 747-771
25 p.
artikel
30 Anal cancer – What is the optimum chemoradiotherapy? Vinayan, A.
2016
50-51 4 p. 641-653
13 p.
artikel
31 Anal incontinence Bartolo, David C.C.
2009
50-51 4 p. 505-515
11 p.
artikel
32 Animal models for primary sclerosing cholangitis Vierling, John M.
2001
50-51 4 p. 591-610
20 p.
artikel
33 Animal models in gastrointestinal alcohol research—a short appraisal of the different models and their results Siegmund, Sören
2003
50-51 4 p. 519-542
24 p.
artikel
34 Anorectal and pelvic floor anatomy Stoker, Jaap
2009
50-51 4 p. 463-475
13 p.
artikel
35 Anorectal motor disorders Remes-Troche, Jose M.
2007
50-51 4 p. 733-748
16 p.
artikel
36 Anti-neutrophil antibodies in primary sclerosing cholangitis Terjung, Birgit
2001
50-51 4 p. 629-642
14 p.
artikel
37 Approaches to the diagnosis and grading of hiatal hernia Kahrilas, Peter J.
2008
50-51 4 p. 601-616
16 p.
artikel
38 Autoimmune tests in primary biliary cirrhosis Strassburg, Christian P.
2000
50-51 4 p. 585-599
15 p.
artikel
39 Autoimmunity and primary biliary cirrhosis Mackay, Ian R.
2000
50-51 4 p. 519-533
15 p.
artikel
40 Bile acids, obesity, and the metabolic syndrome Ma, Huijuan
2014
50-51 4 p. 573-583
11 p.
artikel
41 Biotherapy for metastatic endocrine tumours Shah, Tahir
2005
50-51 4 p. 617-636
20 p.
artikel
42 Cancer of the gastric cardia McColl, Kenneth E.L.
2006
50-51 4 p. 687-696
10 p.
artikel
43 Can gastric cancer be prevented by Helicobacter pylori eradication? Malfertheiner, Peter
2006
50-51 4 p. 709-719
11 p.
artikel
44 Can image-enhanced cholangioscopy distinguish benign from malignant lesions in the biliary duct? Ishida, Yusuke
2015
50-51 4 p. 611-625
15 p.
artikel
45 Central nervous system involvement in functional gastrointestinal disorders Van Oudenhove, Lukas
2004
50-51 4 p. 663-680
18 p.
artikel
46 Characterization of lesions in the stomach: Will confocal laser endomicroscopy replace the pathologist? Goetz, Martin
2015
50-51 4 p. 589-599
11 p.
artikel
47 Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours O'Toole, Dermot
2005
50-51 4 p. 585-594
10 p.
artikel
48 Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction Hulshof, M.C.C.M.
2016
50-51 4 p. 551-563
13 p.
artikel
49 Chemoradiotherapy, the backbone of radiotherapy in gastrointestinal oncology Brunner, Thomas B.
2016
50-51 4 p. 511-513
3 p.
artikel
50 Chemotherapeutic agents for GI tumor chemoradiotherapy overview of chemotherapeutic agents to be combined with radiotherapy in the GI tract and their potential as radiosensitizers Klautke, G.
2016
50-51 4 p. 529-535
7 p.
artikel
51 Chemotherapy Arnold, R.
2005
50-51 4 p. 649-656
8 p.
artikel
52 Chronic intestinal pseudo-obstruction Cogliandro, Rosanna F.
2007
50-51 4 p. 657-669
13 p.
artikel
53 Chronic pelvic pain Baranowski, Andrew Paul
2009
50-51 4 p. 593-610
18 p.
artikel
54 Clinical features and differential diagnosis of diverticular disease Fearnhead, Nicola S.
2002
50-51 4 p. 577-593
17 p.
artikel
55 Colorectal cancer screening in an expanding panorama of screening programmes Hoff, Geir
2010
50-51 4 p. 521-527
7 p.
artikel
56 Colorectal endoscopic mucosal resection (EMR) Kandel, Pujan
2017
50-51 4 p. 455-471
17 p.
artikel
57 Colorectal endoscopic submucosal dissection (ESD) Fuccio, Lorenzo
2017
50-51 4 p. 473-480
8 p.
artikel
58 Complex pelvic floor failure and associated problems Elneil, Sohier
2009
50-51 4 p. 555-573
19 p.
artikel
59 Complicated diverticulosis Boulos, P.B.
2002
50-51 4 p. 649-662
14 p.
artikel
60 Complications of bariatric surgery: Dumping syndrome, reflux and vitamin deficiencies Tack, Jan
2014
50-51 4 p. 741-749
9 p.
artikel
61 Constipation Bharucha, Adil E.
2007
50-51 4 p. 709-731
23 p.
artikel
62 Constipation and evacuation disorders Chatoor, Dave
2009
50-51 4 p. 517-530
14 p.
artikel
63 Contribution of histology to the diagnosis of reflux disease Vieth, Michael
2008
50-51 4 p. 625-638
14 p.
artikel
64 Cost-effectiveness of colorectal cancer screening – An overview Lansdorp-Vogelaar, Iris
2010
50-51 4 p. 439-449
11 p.
artikel
65 Definition and epidemiology of functional gastrointestinal disorders Corazziari, Enrico
2004
50-51 4 p. 613-631
19 p.
artikel
66 Destruction of bile ducts in primary biliary cirrhosis Nakanuma, Yasuni
2000
50-51 4 p. 549-570
22 p.
artikel
67 Detection and characterization of early malignancy in the esophagus: What is the best management algorithm? Singh, Rajvinder
2015
50-51 4 p. 533-544
12 p.
artikel
68 Detection and treatment of early cancer in high-risk populations Yoshida, Shigeaki
2006
50-51 4 p. 745-765
21 p.
artikel
69 Diagnostic approach to dyspepsia Bytzer, Peter
2004
50-51 4 p. 681-693
13 p.
artikel
70 Diagnostic approach to suspected irritable bowel syndrome Hatlebakk, J.G.
2004
50-51 4 p. 735-746
12 p.
artikel
71 Distribution of colorectal polyps: Implications for screening Senore, Carlo
2017
50-51 4 p. 481-488
8 p.
artikel
72 Diverticular disease in adolescence Afzal, Nadeem Ahmad
2002
50-51 4 p. 621-634
14 p.
artikel
73 Diverticulitis Buchanan, Gordon N
2002
50-51 4 p. 635-647
13 p.
artikel
74 Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity? van der Aalst, C.M.
2010
50-51 4 p. 465-478
14 p.
artikel
75 Editorial Board 2003
50-51 4 p. iii-
1 p.
artikel
76 Effect of alcohol consumption on the gut Bode, Christiane
2003
50-51 4 p. 575-592
18 p.
artikel
77 Effect of alcohol on iron storage diseases of the liver Fletcher, Linda M
2003
50-51 4 p. 663-677
15 p.
artikel
78 Endoscopic approaches to Barrett's oesophagus with high-grade dysplasia/early mucosal cancer Ginsberg, Gregory G.
2008
50-51 4 p. 751-772
22 p.
artikel
79 Endoscopic grading of reflux oesophagitis: The past, present and future Dent, John
2008
50-51 4 p. 585-599
15 p.
artikel
80 Endoscopic treatment: The past, the present and the future Mathus-Vliegen, E.M.H.
2014
50-51 4 p. 685-702
18 p.
artikel
81 Eosinophilic oesophagitis and other non-reflux inflammatory conditions of the oesophagus: Diagnostic imaging and management Attwood, Stephen E.A.
2008
50-51 4 p. 639-660
22 p.
artikel
82 Epidemiology and risk factors of colorectal polyps Øines, Mari
2017
50-51 4 p. 419-424
6 p.
artikel
83 Epidemiology of diverticular disease Jun, Stephanie
2002
50-51 4 p. 529-542
14 p.
artikel
84 Epidemiology of primary sclerosing cholangitis Schrumpf, Erik
2001
50-51 4 p. 553-562
10 p.
artikel
85 Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract Klöppel, Günter
2005
50-51 4 p. 507-517
11 p.
artikel
86 Erratum to “Maternal morbidity and mortality in in-vitro Fertilisation” [Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 22 (2008) 549–558] Källén, Bengt
2008
50-51 4 p. 773-
1 p.
artikel
87 Erratum to ‘Pathogenesis of gallstones: a genetic perspective’ [Best Practice & Research Clinical Gastroenterology 20 (2006) 997–1015] Grünhage, Frank
2007
50-51 4 p. 749-751
3 p.
artikel
88 Evaluation and management of gastric epithelial polyps Castro, R.
2017
50-51 4 p. 381-387
7 p.
artikel
89 Evidence for colorectal cancer screening Bretthauer, Michael
2010
50-51 4 p. 417-425
9 p.
artikel
90 Familial gastric cancer – aetiology and pathogenesis Barber, Miriam
2006
50-51 4 p. 721-734
14 p.
artikel
91 Familial gastric cancer – clinical management Fitzgerald, Rebecca C.
2006
50-51 4 p. 735-743
9 p.
artikel
92 Functional dyspepsia: drugs for new (and old) therapeutic targets Cremonini, Filippo
2004
50-51 4 p. 717-733
17 p.
artikel
93 Functional dyspepsia (FD) and non-erosive reflux disease (NERD): overlapping or discrete entities? Quigley, Eamonn M.M.
2004
50-51 4 p. 695-706
12 p.
artikel
94 Gastric cancer adjuvant therapy Lordick, Florian
2016
50-51 4 p. 581-591
11 p.
artikel
95 Gastric cancer: global pattern of the disease and an overview of environmental risk factors Forman, D.
2006
50-51 4 p. 633-649
17 p.
artikel
96 Gastric motor disorders Tack, J.
2007
50-51 4 p. 633-644
12 p.
artikel
97 Gastrooesophageal reflux disease Richter, Joel E.
2007
50-51 4 p. 609-631
23 p.
artikel
98 Gastro-oesophageal reflux disease and obesity: Pathogenesis and response to treatment Mion, François
2014
50-51 4 p. 611-622
12 p.
artikel
99 Genetic polymorphisms in alcoholic pancreatitis Hanck, Christoph
2003
50-51 4 p. 613-623
11 p.
artikel
100 Gut microbiota and obesity: Role in aetiology and potential therapeutic target Moran, Carthage P.
2014
50-51 4 p. 585-597
13 p.
artikel
101 Haemorrhoids, rectal prolapse, anal fissure, peri-anal fistulae and sexually transmitted diseases Felt-Bersma, Richelle J.F.
2009
50-51 4 p. 575-592
18 p.
artikel
102 Hepatic changes in systemic infection Srivastava, Brijesh
2013
50-51 4 p. 485-495
11 p.
artikel
103 Hepatitis C virus and hepatocellular carcinoma Colombo, Massimo
1999
50-51 4 p. 519-528
10 p.
artikel
104 Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis Bergquist, Annika
2001
50-51 4 p. 643-656
14 p.
artikel
105 Hereditary or sporadic polyposis syndromes Basso, Gianluca
2017
50-51 4 p. 409-417
9 p.
artikel
106 High-resolution microendoscopy in differentiating neoplastic from non-neoplastic colorectal polyps Louie, Justin S.
2015
50-51 4 p. 663-673
11 p.
artikel
107 Histological and molecular classification of gastrointestinal polyps Haumaier, Franziska
2017
50-51 4 p. 369-379
11 p.
artikel
108 Histological assessment of oesophageal columnar mucosa Flejou, Jean-François
2008
50-51 4 p. 671-686
16 p.
artikel
109 How to enhance physician and public acceptance and utilisation of colon cancer screening recommendations Senore, Carlo
2010
50-51 4 p. 509-520
12 p.
artikel
110 How to improve drug development for functional disorders Tack, Jan
2004
50-51 4 p. 787-796
10 p.
artikel
111 Image-enhanced capsule endoscopy for characterization of small bowel lesions Van Gossum, André
2015
50-51 4 p. 525-531
7 p.
artikel
112 Image-enhanced endoscopy: Clinical frontier and future perspectives Siersema, Peter D.
2015
50-51 4 p. 523-524
2 p.
artikel
113 Image-enhanced endoscopy technology in the gastrointestinal tract: What is available? Beg, Sabina
2015
50-51 4 p. 627-638
12 p.
artikel
114 Imaging diverticular disease Halligan, Steve
2002
50-51 4 p. 595-610
16 p.
artikel
115 Imaging pelvic floor dysfunction Taylor, Stuart A.
2009
50-51 4 p. 487-503
17 p.
artikel
116 Immunogenetics in PSC Donaldson, Peter T.
2001
50-51 4 p. 611-627
17 p.
artikel
117 Immunology of hepatitis C virus infections Spaan, Michelle
2012
50-51 4 p. 391-400
10 p.
artikel
118 Index 2001
50-51 4 p. I1-I2
nvt p.
artikel
119 Index 1999
50-51 4 p. 655-660
6 p.
artikel
120 Index 2000
50-51 4 p. I1-I7
nvt p.
artikel
121 Inflammation as a basis for functional GI disorders Spiller, R.C.
2004
50-51 4 p. 641-661
21 p.
artikel
122 Introduction: Definition, historical aspects, classification, staging, prognosis and therapeutic options Arnold, R.
2005
50-51 4 p. 491-505
15 p.
artikel
123 In vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy Tsujino, Takeshi
2015
50-51 4 p. 601-610
10 p.
artikel
124 Irritable bowel syndrome and bloating Hasler, William L.
2007
50-51 4 p. 689-707
19 p.
artikel
125 Liver abnormalities and endocrine diseases Burra, Patrizia
2013
50-51 4 p. 553-563
11 p.
artikel
126 Liver abnormalities in bowel diseases Kummen, Martin
2013
50-51 4 p. 531-542
12 p.
artikel
127 Liver abnormalities in connective tissue diseases De Santis, Maria
2013
50-51 4 p. 543-551
9 p.
artikel
128 Liver abnormalities in drug and substance abusers Pateria, Puraskar
2013
50-51 4 p. 577-596
20 p.
artikel
129 Liver abnormalities in pregnancy Than, Nwe Ni
2013
50-51 4 p. 565-575
11 p.
artikel
130 Liver abnormalities in the immunosuppressed Cheung, Michelle C.M.
2013
50-51 4 p. 597-618
22 p.
artikel
131 Liver disease and malnutrition Purnak, Tugrul
2013
50-51 4 p. 619-629
11 p.
artikel
132 Liver disease in alcohol and hepatitis C Jamal, M.Mazen
2003
50-51 4 p. 649-662
14 p.
artikel
133 Liver in cardiopulmonary disease Polavarapu, Naveen
2013
50-51 4 p. 497-512
16 p.
artikel
134 Liver in haematological disorders Pieri, Giulia
2013
50-51 4 p. 513-530
18 p.
artikel
135 Liver transplantation for malignant disease Heneghan, Michael A
1999
50-51 4 p. 575-591
17 p.
artikel
136 Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease Wiesner, Russell H.
2001
50-51 4 p. 667-680
14 p.
artikel
137 Liver transplantation in the setting of chronic HCV Terrault, Norah
2012
50-51 4 p. 531-548
18 p.
artikel
138 Locoregional treatments for hepatocellular carcinoma Bruix, Jordi
1999
50-51 4 p. 611-622
12 p.
artikel
139 Management of duodenal polyps Ma, Michael X.
2017
50-51 4 p. 389-399
11 p.
artikel
140 Management of hepatitis C in HIV and/or HBV co-infected patients Fernández-Montero, José Vicente
2012
50-51 4 p. 517-530
14 p.
artikel
141 Management of metastatic endocrine tumours Plöckinger, U.
2005
50-51 4 p. 553-576
24 p.
artikel
142 Management of osteoporosis in primary biliary cirrhosis Wolfhagen, Frank H.J
2000
50-51 4 p. 629-641
13 p.
artikel
143 Management of radiation and chemotherapy related acute toxicity in gastrointestinal cancer Grabenbauer, Gerhard G.
2016
50-51 4 p. 655-664
10 p.
artikel
144 Management of small bowel polyps: A literature review de Latour, Rabia A.
2017
50-51 4 p. 401-408
8 p.
artikel
145 Mechanisms behind the link between obesity and gastrointestinal cancers Tilg, Herbert
2014
50-51 4 p. 599-610
12 p.
artikel
146 Mechanisms of liver involvement in systemic disease Edwards, Lori
2013
50-51 4 p. 471-483
13 p.
artikel
147 Mechanisms of the antitumoural effects of aspirin in the gastrointestinal tract Bruno, Annalisa
2012
50-51 4 p. e1-e13
nvt p.
artikel
148 Medical and endoscopic treatment in primary sclerosing cholangitis Meier, Peter N.
2001
50-51 4 p. 657-666
10 p.
artikel
149 Medical management of diverticular disease Murray, Charles D.R
2002
50-51 4 p. 611-620
10 p.
artikel
150 Medical treatment of obesity: The past, the present and the future Bray, George A.
2014
50-51 4 p. 665-684
20 p.
artikel
151 Meetings Announcement 2005
50-51 4 p. 657-
1 p.
artikel
152 Metabolic surgery: Action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature Sweeney, Timothy E.
2014
50-51 4 p. 727-740
14 p.
artikel
153 Methods to become a high performer in characterization of colorectal polyp histology Saligram, Shreyas
2015
50-51 4 p. 651-662
12 p.
artikel
154 Molecular basis of functional gastrointestinal disorders Holtmann, Gerald
2004
50-51 4 p. 633-640
8 p.
artikel
155 Molecular biomarkers added to image-enhanced endoscopic imaging: Will they further improve diagnostic accuracy? Krishnamoorthi, Rajesh
2015
50-51 4 p. 561-573
13 p.
artikel
156 Monitoring response to treatment in liver tumours Yang, W.T.
1999
50-51 4 p. 637-654
18 p.
artikel
157 Morphological classifications of gastrointestinal lesions Vleugels, Jasper L.A.
2017
50-51 4 p. 359-367
9 p.
artikel
158 Natural history and prognostic models in primary sclerosing cholangitis Talwalkar, Jayant A.
2001
50-51 4 p. 563-575
13 p.
artikel
159 Natural history of acute and chronic hepatitis C Maasoumy, Benjamin
2012
50-51 4 p. 401-412
12 p.
artikel
160 Neurogenic colorectal and pelvic floor dysfunction Krogh, Klaus
2009
50-51 4 p. 531-543
13 p.
artikel
161 Neuromodulation for functional bowel disorders Govaert, B.
2009
50-51 4 p. 545-553
9 p.
artikel
162 New approaches to the investigation of focal hepatic lesions Li, King C.P.
1999
50-51 4 p. 529-543
15 p.
artikel
163 New kid on the block? Autoimmune pancreatitis Forcione, David G.
2010
50-51 4 p. 361-378
18 p.
artikel
164 New targets for treatment against HCV infection Pan, Qiuwei
2012
50-51 4 p. 505-515
11 p.
artikel
165 Non-achalasic motor disorders of the oesophagus Sifrim, Daniel
2007
50-51 4 p. 575-593
19 p.
artikel
166 Non-alcoholic fatty liver disease, obesity and the metabolic syndrome Dietrich, Peter
2014
50-51 4 p. 637-653
17 p.
artikel
167 Non-surgical treatment for liver metastases Kemeny, Nancy E.
1999
50-51 4 p. 593-610
18 p.
artikel
168 Novel imaging modalities in the detection of oesophageal neoplasia Curvers, W.L.
2008
50-51 4 p. 687-720
34 p.
artikel
169 Obesity and the gastrointestinal tract Mathus-Vliegen, E.M.H.
2014
50-51 4 p. 531-532
2 p.
artikel
170 Obesity and the risk and prognosis of gallstone disease and pancreatitis Bonfrate, Leonilde
2014
50-51 4 p. 623-635
13 p.
artikel
171 Oesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignancies Adebahr, Sonja
2016
50-51 4 p. 565-580
16 p.
artikel
172 Optical diagnosis of small colorectal polyps during colonoscopy: When to resect and discard? Wilson, Ana
2015
50-51 4 p. 639-649
11 p.
artikel
173 Organising a clinical service for patients with pelvic floor disorders Chatoor, Dave
2009
50-51 4 p. 611-620
10 p.
artikel
174 Pancreatic cancer chemoradiotherapy Brunner, Thomas B.
2016
50-51 4 p. 617-628
12 p.
artikel
175 Pathology and molecular biology of gastric cancer Vauhkonen, Matti
2006
50-51 4 p. 651-674
24 p.
artikel
176 Pathophysiology of diverticular disease Mimura, Toshiki
2002
50-51 4 p. 563-576
14 p.
artikel
177 Pathophysiology of functional dyspepsia Lee, Kwang-Jae
2004
50-51 4 p. 707-716
10 p.
artikel
178 Peptide receptor radionuclide therapy Teunissen, Jaap J.M.
2005
50-51 4 p. 595-616
22 p.
artikel
179 Performance improvements of imaging-based screening tests Hassan, Cesare
2010
50-51 4 p. 493-507
15 p.
artikel
180 Performance improvements of stool-based screening tests van Dam, Leonie
2010
50-51 4 p. 479-492
14 p.
artikel
181 Polyp characterization at colonoscopy: Clinical implications Allen, James E.
2017
50-51 4 p. 435-440
6 p.
artikel
182 Polyp detection at colonoscopy: Endoscopist and technical factors Rex, Douglas K.
2017
50-51 4 p. 425-433
9 p.
artikel
183 Potential contribution of novel imaging modalities in non-erosive reflux disease Gossner, Liebwin
2008
50-51 4 p. 617-624
8 p.
artikel
184 Preface Emmanuel, Anton
2009
50-51 4 p. 461-
1 p.
artikel
185 Preface Singer, Manfred V.
2003
50-51 4 p. 495-
1 p.
artikel
186 Preface Emmanuel, Anton
2002
50-51 4 p. 527-
1 p.
artikel
187 Preface 2000
50-51 4 p. vii-viii
nvt p.
artikel
188 Preface 2001
50-51 4 p. vii-
1 p.
artikel
189 Preface Johnson, Philip J.
1999
50-51 4 p. vii-viii
nvt p.
artikel
190 Preface Janssen, Harry
2012
50-51 4 p. 369-
1 p.
artikel
191 Preface McColl, Kenneth E.L.
2006
50-51 4 p. 631-
1 p.
artikel
192 Preface Tack, J.
2004
50-51 4 p. 611-
1 p.
artikel
193 Preface Boeckxstaens, G.E.E.
2007
50-51 4 p. 561-
1 p.
artikel
194 Preface Segnan, Nereo
2010
50-51 4 p. 379-380
2 p.
artikel
195 Preface 2005
50-51 4 p. 489-
1 p.
artikel
196 Preface Dent, John
2008
50-51 4 p. 551-
1 p.
artikel
197 Preface: The liver in systemic disease Neuberger, James
2013
50-51 4 p. 469-
1 p.
artikel
198 Preface to gastrointestinal polyps Hassan, C.
2017
50-51 4 p. 357-
1 p.
artikel
199 Prospects for hepatitis B virus eradication and control of hepatocellular carcinoma Chang, Mei-Hwei
1999
50-51 4 p. 511-517
7 p.
artikel
200 Pruritus and fatigue in primary biliary cirrhosis Bergasa, Nora V
2000
50-51 4 p. 643-655
13 p.
artikel
201 Public health issues of hepatitis C virus infection Papatheodoridis, George
2012
50-51 4 p. 371-380
10 p.
artikel
202 Publisher’s Note 2010
50-51 4 p. 359-
1 p.
artikel
203 Quality assurance of endoscopy in colorectal cancer screening Valori, Roland
2010
50-51 4 p. 451-464
14 p.
artikel
204 Radiation therapy in cholangiocellular carcinomas Brunner, Thomas B.
2016
50-51 4 p. 593-602
10 p.
artikel
205 Rectal cancer: Neoadjuvant chemoradiotherapy Rödel, Claus
2016
50-51 4 p. 629-639
11 p.
artikel
206 Recurrent primary biliary cirrhosis Neuberger, James
2000
50-51 4 p. 669-680
12 p.
artikel
207 Red flag imaging in Barrett's esophagus: Does it help to find the needle in the haystack? Gonzalez-Haba, Mariano
2015
50-51 4 p. 545-560
16 p.
artikel
208 Reprint of: The natural history of adenomas Risio, Mauro
2010
50-51 4 p. 397-406
10 p.
artikel
209 Response guided therapy in patients with chronic hepatitis C – Yesterday, today and tomorrow Ferenci, Peter
2012
50-51 4 p. 463-469
7 p.
artikel
210 Role of host genes in sporadic gastric cancer El-Omar, Emad M.
2006
50-51 4 p. 675-686
12 p.
artikel
211 Sclerosing cholangitis in the paediatric patient Mieli-Vergani, Giorgina
2001
50-51 4 p. 681-690
10 p.
artikel
212 Screening for hepatocellular carcinoma Sherman, Morris
1999
50-51 4 p. 623-635
13 p.
artikel
213 Second generation direct antivirals and the way to interferon-free regimens in chronic HCV Lewis, Heather
2012
50-51 4 p. 471-485
15 p.
artikel
214 Serrated lesions of the colon and rectum: The role of advanced endoscopic imaging Vleugels, J.L.A.
2015
50-51 4 p. 675-686
12 p.
artikel
215 Severe gastroparesis: New treatment alternatives Abrahamsson, Hasse
2007
50-51 4 p. 645-655
11 p.
artikel
216 Should patients with Barrett's oesophagus be kept under surveillance? The case against Barritt IV, A. Sidney
2008
50-51 4 p. 741-750
10 p.
artikel
217 Should patients with Barrett's oesophagus be kept under surveillance? The case for Armstrong, David
2008
50-51 4 p. 721-739
19 p.
artikel
218 Simulation of colorectal cancer screening: What we do and do not know and does it matter van Ballegooijen, Marjolein
2010
50-51 4 p. 427-437
11 p.
artikel
219 Somatostatin receptors as tools for diagnosis and therapy: Molecular aspects Guillermet-Guibert, Julie
2005
50-51 4 p. 535-551
17 p.
artikel
220 Standardisation of polypectomy technique Moss, Alan
2017
50-51 4 p. 447-453
7 p.
artikel
221 Stereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care Méndez Romero, Alejandra
2016
50-51 4 p. 603-616
14 p.
artikel
222 Surgical treatment of malignant liver tumours DeMatteo, Ronald P.
1999
50-51 4 p. 557-574
18 p.
artikel
223 Surgical treatment of neuroendocrine metastases Norton, Jeffrey A.
2005
50-51 4 p. 577-583
7 p.
artikel
224 Surveillance of long-standing colitis: The role of image-enhanced endoscopy ten Hove, Joren R.
2015
50-51 4 p. 687-697
11 p.
artikel
225 Swallowing disorders Logemann, Jeri A.
2007
50-51 4 p. 563-573
11 p.
artikel
226 Symptoms and diagnosis of gastric cancer at early curable stage Axon, Anthony
2006
50-51 4 p. 697-708
12 p.
artikel
227 Targeted agents in GI radiotherapy: Clinical efficacy and side effects Fokas, Emmanouil
2016
50-51 4 p. 537-549
13 p.
artikel
228 Targeting risk groups for screening Regula, Jaroslaw
2010
50-51 4 p. 407-416
10 p.
artikel
229 The aetiology of obesity beyond eating more and exercising less Dhurandhar, Emily J.
2014
50-51 4 p. 533-544
12 p.
artikel
230 The cooperation between endoscopists and surgeons in treating complications of bariatric surgery Mathus-Vliegen, E.M.H.
2014
50-51 4 p. 703-725
23 p.
artikel
231 The dimensions of the CRC problem Karsa, L.v.
2010
50-51 4 p. 381-396
16 p.
artikel
232 The gut–brain axis in obesity Buhmann, Helena
2014
50-51 4 p. 559-571
13 p.
artikel
233 The normal anatomy around the oesophagogastric junction: A histopathologic view and its correlation with endoscopy Takubo, Kaiyo
2008
50-51 4 p. 569-583
15 p.
artikel
234 The normal anatomy around the oesophagogastric junction: An endoscopic view Boyce, H. Worth
2008
50-51 4 p. 553-567
15 p.
artikel
235 The pathology of diverticular disease Ludeman, Linmarie
2002
50-51 4 p. 543-562
20 p.
artikel
236 The pathology of primary biliary cirrhosis and autoimmune cholangitis Ludwig, Jurgen
2000
50-51 4 p. 601-613
13 p.
artikel
237 The pathophysiology of cholestasis with special reference to primary biliary cirrhosis Jansen, Peter L.M
2000
50-51 4 p. 571-583
13 p.
artikel
238 The physiology of continence and evacuation Bajwa, Adeel
2009
50-51 4 p. 477-485
9 p.
artikel
239 The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis Nishio, Akiyoshi
2000
50-51 4 p. 535-547
13 p.
artikel
240 Therapy and supportive care of alcoholics: guidelines for practitioners Heinz, Andreas
2003
50-51 4 p. 695-708
14 p.
artikel
241 The rationale of combined radiotherapy and chemotherapy – Joint action of Castor and Pollux Brunner, Thomas B.
2016
50-51 4 p. 515-528
14 p.
artikel
242 The risk of colonic adenomas and colonic cancer in obesity Laiyemo, Adeyinka O.
2014
50-51 4 p. 655-663
9 p.
artikel
243 The role of chemotherapy in patients with established gastric cancer Wagner, Anna D.
2006
50-51 4 p. 789-799
11 p.
artikel
244 The role of resistance in HCV treatment Vermehren, Johannes
2012
50-51 4 p. 487-503
17 p.
artikel
245 The role of surgery in patients with advanced gastric cancer McCulloch, Peter
2006
50-51 4 p. 767-787
21 p.
artikel
246 The role of viral and host genetics in natural history and treatment of chronic HCV infection Doyle, Joseph S.
2012
50-51 4 p. 413-427
15 p.
artikel
247 The timing of liver transplantation in primary biliary cirrhosis Angulo, Paul
2000
50-51 4 p. 657-668
12 p.
artikel
248 Transplantation in the management of metastatic endocrine tumours Pascher, Andreas
2005
50-51 4 p. 637-648
12 p.
artikel
249 Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection Feld, Jordan J.
2012
50-51 4 p. 429-444
16 p.
artikel
250 Treatment of primary biliary cirrhosis Poupon, Raoul
2000
50-51 4 p. 615-628
14 p.
artikel
251 Treatment options in irritable bowel syndrome Farthing, Michael J.G.
2004
50-51 4 p. 773-786
14 p.
artikel
252 Triple therapy with boceprevir or telaprevir for prior HCV non-responders Asselah, Tarik
2012
50-51 4 p. 455-462
8 p.
artikel
253 Triple therapy with boceprevir or telaprevir for treatment naïve HCV patients Esteban, Rafael
2012
50-51 4 p. 445-453
9 p.
artikel
254 Virology of hepatitis C virus infection Chevaliez, Stéphane
2012
50-51 4 p. 381-389
9 p.
artikel
255 When and how to grade Barrett's columnar metaplasia: The Prague system Anand, Oksana
2008
50-51 4 p. 661-669
9 p.
artikel
                             255 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland